CNS Co.,Ltd Fundamental Analysis (JPX: 4076.T)
CNS Co.,Ltd (JPX: 4076.T) shows moderate financial fundamentals with a PE ratio of 9.93, profit margin of 7.60%, and ROE of 14.41%. The company generates $7.8B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 81.4/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 4076.T's fundamental strength across five key dimensions:
Efficiency Score
Excellent4076.T demonstrates superior asset utilization.
Valuation Score
Excellent4076.T trades at attractive valuation levels.
Growth Score
Moderate4076.T shows steady but slowing expansion.
Financial Health Score
Excellent4076.T maintains a strong and stable balance sheet.
Profitability Score
Weak4076.T struggles to sustain strong margins.
Key Financial Metrics
Is 4076.T Expensive or Cheap?
P/E Ratio
4076.T trades at 9.93 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 4076.T's PEG of 0.26 indicates potential undervaluation.
Price to Book
The market values CNS Co.,Ltd at 1.35 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 11.57 times EBITDA. This signals the market has high growth expectations.
How Well Does 4076.T Make Money?
Net Profit Margin
For every $100 in sales, CNS Co.,Ltd keeps $7.60 as profit after all expenses.
Operating Margin
Core operations generate 8.82 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $14.41 in profit for every $100 of shareholder equity.
ROA
CNS Co.,Ltd generates $10.09 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CNS Co.,Ltd generates limited operating cash flow of $579.88M, signaling weaker underlying cash strength.
Free Cash Flow
CNS Co.,Ltd generates weak or negative free cash flow of $174.50M, restricting financial flexibility.
FCF Per Share
Each share generates $60.05 in free cash annually.
FCF Yield
4076.T converts 2.98% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
9.93
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.26
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.35
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.75
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.001
vs 25 benchmark
Current Ratio
Current assets to current liabilities
4.47
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.14
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.14
vs 25 benchmark
How 4076.T Stacks Against Its Sector Peers
| Metric | 4076.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 9.93 | 35.30 | Better (Cheaper) |
| ROE | 14.41% | 752.00% | Weak |
| Net Margin | 7.60% | -2918.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.60 | Strong (Low Leverage) |
| Current Ratio | 4.47 | 6.15 | Strong Liquidity |
| ROA | 10.09% | 323.00% | Weak |
4076.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CNS Co.,Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Innovation, High Beta
EPS CAGR
N/A
Industry Style: Growth, Innovation, High Beta
FCF CAGR
N/A
Industry Style: Growth, Innovation, High Beta